share_log
Moomoo 24/7 ·  03/22 09:29

Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement

Intellia Therapeutics於3月19日通知Regeneron Pharmicals,該公司選擇退出其Factor IX共同開發和聯合資助協議

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論